SECUKINUMAB

SECUKINUMAB was reported 161904 times

SECUKINUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC ENZYME 101 0.6779
1 REBOUND PSORIASIS 389 0.6695
2 GRIP STRENGTH 148 0.6463
3 C-REACTIVE PROTEIN 594 0.6408
4 FACET JOINT SYNDROME 2062 0.6327
5 DEEP VEIN THROMBOSIS POSTOPERATIVE 1254 0.6261
6 LUPUS VULGARIS 788 0.6254
7 RHEUMATIC FEVER 2668 0.5979
8 SWOLLEN JOINT COUNT INCREASED 1809 0.5667
9 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 372 0.5569
10 SWOLLEN JOINT COUNT 139 0.5560
11 HYPOCHOLESTEROLAEMIA 188 0.5326
12 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 999 0.4817
13 DISLOCATION OF VERTEBRA 1092 0.4783
14 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 252 0.4492
15 X-RAY ABNORMAL 804 0.4492
16 DUODENAL ULCER PERFORATION 3150 0.4232
17 RED BLOOD CELL SEDIMENTATION RATE 118 0.4229
18 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3015 0.4204
19 RETINITIS 719 0.4158
20 PERIPHERAL VENOUS DISEASE 1662 0.4066
21 RHEUMATOID FACTOR POSITIVE 2300 0.3978
22 NEUROLOGIC NEGLECT SYNDROME 195 0.3507
23 C-REACTIVE PROTEIN ABNORMAL 2116 0.3295
24 PEMPHIGUS 3990 0.3188
25 SERONEGATIVE ARTHRITIS 360 0.3141
26 HELICOBACTER INFECTION 3170 0.3081
27 MUSCLE INJURY 2508 0.3024
28 FOLLICULITIS 3173 0.3023
29 DACTYLITIS 291 0.2963
30 NAIL PSORIASIS 181 0.2929
31 HAND DEFORMITY 3786 0.2884
32 ENTHESOPATHY 451 0.2882
33 MACULE 748 0.2695
34 PSORIATIC ARTHROPATHY 10387 0.2556
35 SKIN PLAQUE 2104 0.2492
36 BREAST CANCER STAGE III 1612 0.2487
37 SYNOVITIS 4296 0.2380
38 BONE EROSION 836 0.2362
39 LIP DRY 2130 0.2343
40 CAROTID ARTERY THROMBOSIS 196 0.2309
41 ONYCHOMADESIS 957 0.2278
42 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 1477 0.2272
43 PORPHYRIA ACUTE 324 0.2258
44 GRIP STRENGTH DECREASED 1866 0.2118
45 PERICARDITIS 3489 0.2075
46 BURSITIS 2407 0.1982
47 NAIL PITTING 76 0.1919
48 GLOSSODYNIA 4142 0.1848
49 JOINT RANGE OF MOTION DECREASED 2473 0.1842
50 WOUND INFECTION 2002 0.1826
51 LENTIGO 87 0.1754
52 PSORIASIS 22918 0.1753
53 JOINT ANKYLOSIS 99 0.1743
54 BLEPHAROSPASM 1091 0.1731
55 HYPERCHOLESTEROLAEMIA 1633 0.1690
56 DRUG TOLERANCE DECREASED 473 0.1683
57 PALMOPLANTAR PUSTULOSIS 89 0.1682
58 OVERLAP SYNDROME 117 0.1671
59 ANKYLOSING SPONDYLITIS 2123 0.1609
60 FINGER DEFORMITY 774 0.1596
61 LIVE BIRTH 1310 0.1564
62 GUTTATE PSORIASIS 127 0.1547
63 ONYCHOMYCOSIS 678 0.1544
64 WOUND 4310 0.1540
65 FIBROMYALGIA 3660 0.1504
66 PUSTULAR PSORIASIS 517 0.1504
67 NAIL DISORDER 1315 0.1501
68 ADJUSTMENT DISORDER 192 0.1477
69 SPONDYLOARTHROPATHY 87 0.1450
70 AUTOIMMUNE DISORDER 1407 0.1442
71 IRRITABLE BOWEL SYNDROME 3074 0.1432
72 JOINT DESTRUCTION 219 0.1407
73 INFLAMMATORY PAIN 94 0.1384
74 AXIAL SPONDYLOARTHRITIS 121 0.1377
75 LIVER INJURY 3290 0.1339
76 HAEMANGIOMA OF SKIN 56 0.1284
77 SACRAL PAIN 78 0.1283
78 GRANULOMA SKIN 103 0.1255
79 HYPERMOBILITY SYNDROME 61 0.1225
80 SYSTEMIC LUPUS ERYTHEMATOSUS 4318 0.1215
81 SACROILIITIS 222 0.1175
82 OBESITY 1850 0.1160
83 SEBORRHOEIC KERATOSIS 168 0.1156
84 LOWER RESPIRATORY TRACT INFECTION VIRAL 56 0.1107
85 CONTRAINDICATED PRODUCT ADMINISTERED 3293 0.1087
86 MATERNAL EXPOSURE TIMING UNSPECIFIED 408 0.1085
87 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1173 0.1059
88 INFUSION SITE REACTION 311 0.1040
89 TYPE 2 DIABETES MELLITUS 3391 0.1006
90 PRODUCT LABEL CONFUSION 585 0.1003
91 SCIATICA 1585 0.0993
92 LOWER RESPIRATORY TRACT INFECTION 4475 0.0983
93 EXOSTOSIS 876 0.0958
94 BACK INJURY 1038 0.0954
95 VULVOVAGINAL CANDIDIASIS 129 0.0953
96 TENOSYNOVITIS 255 0.0924
97 IMPAIRED HEALING 3001 0.0913
98 ERYTHRODERMIC PSORIASIS 75 0.0910
99 DECREASED IMMUNE RESPONSIVENESS 880 0.0896
100 SPONDYLITIS 320 0.0879
101 GAIT INABILITY 2937 0.0878
102 BLOOD PARATHYROID HORMONE DECREASED 130 0.0877
103 ARTHROPATHY 4700 0.0845
104 INFLAMMATION 4221 0.0817
105 LOWER LIMB FRACTURE 1566 0.0814
106 LUPUS-LIKE SYNDROME 728 0.0802
107 PUSTULE 189 0.0797
108 PRESCRIBED OVERDOSE 1520 0.0785
109 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1342 0.0782
110 DEVICE DISPENSING ERROR 92 0.0779
111 CONCOMITANT DISEASE AGGRAVATED 479 0.0775
112 DERMATITIS PSORIASIFORM 158 0.0773
113 C-REACTIVE PROTEIN INCREASED 2810 0.0772
114 THERAPEUTIC PRODUCT EFFECT DECREASED 3449 0.0769
115 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 177 0.0768
116 PERSONALITY DISORDER 200 0.0763
117 ALANINE AMINOTRANSFERASE ABNORMAL 161 0.0763
118 HIDRADENITIS 690 0.0756
119 PULMONARY FIBROSIS 1451 0.0756
120 TINEA PEDIS 118 0.0739
121 MUSCULOSKELETAL STIFFNESS 6479 0.0739
122 OSTEOARTHRITIS 3101 0.0731
123 NORMAL NEWBORN 397 0.0730
124 MYCOTIC ALLERGY 62 0.0725
125 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5146 0.0723
126 BREAST CANCER STAGE II 597 0.0717
127 SKIN LESION 1930 0.0703
128 PAPULE 489 0.0693
129 COELIAC DISEASE 677 0.0689
130 SKIN HAEMORRHAGE 1018 0.0686
131 NIGHT SWEATS 2206 0.0684
132 FOOT DEFORMITY 747 0.0673
133 ULCER HAEMORRHAGE 446 0.0658
134 BLOOD CHOLESTEROL INCREASED 3060 0.0656
135 BLISTER 3686 0.0656
136 RHEUMATOID NODULE 178 0.0646
137 PANNICULITIS 156 0.0644
138 SYMPTOM RECURRENCE 384 0.0641
139 DEATH NEONATAL 89 0.0639
140 TONSILLITIS 332 0.0636
141 SPINAL PAIN 742 0.0633
142 DRUG TOLERANCE 312 0.0616
143 LIVER FUNCTION TEST INCREASED 1320 0.0614
144 DISCOMFORT 3671 0.0601
145 EYE INJURY 178 0.0585
146 MOBILITY DECREASED 4183 0.0582
147 RHEUMATOID LUNG 55 0.0576
148 RASH VESICULAR 277 0.0572
149 PIGMENTATION DISORDER 351 0.0568
150 JOINT SWELLING 6794 0.0562
151 WALKING AID USER 370 0.0561
152 ARTHRITIS 4399 0.0559
153 HEPATIC ENZYME INCREASED 3798 0.0557
154 ONYCHOLYSIS 87 0.0556
155 POLYARTHRITIS 293 0.0555
156 JOINT DISLOCATION 582 0.0550
157 SWELLING 5072 0.0541
158 TREATMENT FAILURE 4428 0.0534
159 XEROSIS 66 0.0533
160 TASTE DISORDER 1072 0.0528
161 PRODUCT SUPPLY ISSUE 375 0.0525
162 STOMATITIS 3178 0.0523
163 CONGENITAL ANOMALY 400 0.0516
164 JOINT STIFFNESS 1350 0.0514
165 INFUSION RELATED REACTION 3405 0.0513
166 DISCHARGE 71 0.0512
167 TENDERNESS 528 0.0506
168 EAR INFECTION 1344 0.0505
169 WHEEZING 2963 0.0499
170 DRUG INTOLERANCE 4761 0.0492
171 PRESCRIBED UNDERDOSE 979 0.0490
172 UVEITIS 664 0.0489
173 INFLAMMATORY BOWEL DISEASE 475 0.0485
174 HIP ARTHROPLASTY 743 0.0485
175 MUSCULOSKELETAL PAIN 2535 0.0483
176 HEPATIC CIRRHOSIS 904 0.0481
177 PRODUCT TEMPERATURE EXCURSION ISSUE 247 0.0480
178 SKIN HYPERTROPHY 134 0.0476
179 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 113 0.0476
180 LATENT TUBERCULOSIS 99 0.0472
181 LUNG DISORDER 2310 0.0471
182 RHEUMATIC DISORDER 91 0.0470
183 CUTANEOUS T-CELL LYMPHOMA 59 0.0468
184 INCORRECT DOSE ADMINISTERED BY DEVICE 1220 0.0465
185 SKIN FISSURES 907 0.0464
186 IRITIS 141 0.0463
187 RHEUMATOID ARTHRITIS 5246 0.0462
188 RUBBER SENSITIVITY 70 0.0457
189 SKIN DEPIGMENTATION 62 0.0454
190 NECK PAIN 2540 0.0454
191 SEBORRHOEIC DERMATITIS 75 0.0453
192 ACTINIC KERATOSIS 117 0.0450
193 INJURY 3105 0.0441
194 DANDRUFF 97 0.0438
195 IMPETIGO 65 0.0436
196 SINUSITIS 4431 0.0432
197 ILL-DEFINED DISORDER 2626 0.0432
198 NASOPHARYNGITIS 7955 0.0431
199 MATERNAL EXPOSURE DURING PREGNANCY 3836 0.0430
200 ROAD TRAFFIC ACCIDENT 1791 0.0428
201 DEVICE DEFECTIVE 740 0.0427
202 SCAB 484 0.0424
203 PHARYNGITIS STREPTOCOCCAL 455 0.0420
204 ORAL CANDIDIASIS 548 0.0416
205 ERYSIPELAS 209 0.0416
206 ADVERSE REACTION 547 0.0412
207 LIVER DISORDER 1821 0.0410
208 THERAPY NON-RESPONDER 1834 0.0408
209 SKIN MASS 268 0.0401
210 PRODUCT DISTRIBUTION ISSUE 370 0.0398
211 OTORRHOEA 69 0.0395
212 NEOPLASM SKIN 61 0.0393
213 EPILEPSY 1191 0.0389
214 VEIN RUPTURE 65 0.0388
215 NEEDLE ISSUE 1126 0.0386
216 OEDEMA 2085 0.0384
217 EAR PAIN 746 0.0383
218 PLANTAR FASCIITIS 126 0.0375
219 PYODERMA GANGRENOSUM 134 0.0372
220 PERIPHERAL SWELLING 5694 0.0369
221 SKIN EXFOLIATION 3118 0.0369
222 THERAPEUTIC PRODUCT EFFECT DELAYED 168 0.0368
223 DEVICE MALFUNCTION 2578 0.0366
224 KNEE ARTHROPLASTY 771 0.0366
225 SKIN DISORDER 1219 0.0365
226 SCRATCH 385 0.0365
227 ARTHRALGIA 15102 0.0363
228 COSTOCHONDRITIS 59 0.0362
229 GENERAL PHYSICAL HEALTH DETERIORATION 4161 0.0359
230 SLEEP DISORDER 2536 0.0359
231 SKIN INJURY 119 0.0359
232 GASTROINTESTINAL DISORDER 3190 0.0356
233 CANDIDA INFECTION 593 0.0351
234 OESOPHAGEAL CANDIDIASIS 139 0.0348
235 THERAPEUTIC RESPONSE SHORTENED 1153 0.0347
236 PRODUCT PRESCRIBING ERROR 825 0.0346
237 SKIN WOUND 58 0.0341
238 SINUS CONGESTION 460 0.0340
239 SENSORY LOSS 274 0.0340
240 PHARYNGITIS 419 0.0337
241 INFECTION 4848 0.0335
242 SPINAL FUSION SURGERY 135 0.0332
243 DRUG-INDUCED LIVER INJURY 1042 0.0332
244 DRY MOUTH 2643 0.0325
245 ABDOMINAL DISCOMFORT 5461 0.0325
246 FURUNCLE 258 0.0325
247 UPPER RESPIRATORY TRACT INFECTION 1504 0.0325
248 GANGRENE 195 0.0323
249 ORAL FUNGAL INFECTION 88 0.0321
250 DELIRIUM 1112 0.0320
251 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2274 0.0319
252 TUBERCULIN TEST POSITIVE 80 0.0316
253 MELANOCYTIC NAEVUS 138 0.0314
254 DERMATITIS EXFOLIATIVE GENERALISED 108 0.0310
255 MUSCULOSKELETAL DISCOMFORT 532 0.0309
256 APHTHOUS ULCER 239 0.0308
257 GRANULOMA 106 0.0306
258 TOOTH ABSCESS 310 0.0304
259 ABSCESS LIMB 129 0.0302
260 HEPATITIS 774 0.0302
261 MYOSITIS 271 0.0302
262 GENERAL SYMPTOM 226 0.0301
263 FEAR OF INJECTION 212 0.0297
264 DRUG EFFECT INCOMPLETE 1078 0.0296
265 MUSCLE SPASTICITY 361 0.0294
266 SKIN INFECTION 326 0.0290
267 JOINT NOISE 57 0.0290
268 IMMUNODEFICIENCY 432 0.0290
269 ARTERIAL OCCLUSIVE DISEASE 227 0.0289
270 SARS-COV-2 TEST POSITIVE 378 0.0286
271 CONDITION AGGRAVATED 8697 0.0286
272 JOINT EFFUSION 197 0.0285
273 INTENTIONAL PRODUCT USE ISSUE 2502 0.0285
274 INFLUENZA 3177 0.0285
275 THERAPEUTIC PRODUCT INEFFECTIVE 110 0.0284
276 DENGUE FEVER 65 0.0283
277 INFECTION SUSCEPTIBILITY INCREASED 62 0.0283
278 TENDONITIS 438 0.0283
279 HYPERSENSITIVITY 5244 0.0282
280 RHINITIS 227 0.0281
281 ANIMAL BITE 75 0.0281
282 LICHEN PLANUS 65 0.0280
283 EXPOSURE DURING PREGNANCY 1742 0.0280
284 DEVICE LEAKAGE 1214 0.0280
285 SUBCUTANEOUS ABSCESS 134 0.0279
286 CONTUSION 2691 0.0279
287 HEMIPLEGIA 232 0.0279
288 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4998 0.0277
289 SKIN PAPILLOMA 111 0.0277
290 IRIDOCYCLITIS 87 0.0275
291 IMMUNE SYSTEM DISORDER 362 0.0274
292 PAIN 16854 0.0274
293 SKIN NECROSIS 142 0.0273
294 KIDNEY INFECTION 536 0.0273
295 INFLAMMATORY MARKER INCREASED 135 0.0272
296 PRODUCT LEAKAGE 152 0.0271
297 SUSPECTED COVID-19 89 0.0270
298 PAIN OF SKIN 723 0.0268
299 HYPOAESTHESIA 4004 0.0267
300 TONGUE ULCERATION 90 0.0266
301 ACCIDENTAL EXPOSURE TO PRODUCT 2738 0.0265
302 PREGNANCY 530 0.0264
303 LOCALISED INFECTION 639 0.0264
304 HYPOKINESIA 383 0.0264
305 SKIN DISCOMFORT 71 0.0263
306 ARTHRITIS INFECTIVE 122 0.0263
307 OROPHARYNGEAL PAIN 2429 0.0262
308 ALOPECIA 5143 0.0262
309 BACK DISORDER 423 0.0260
310 BREAKTHROUGH PAIN 60 0.0259
311 SECRETION DISCHARGE 323 0.0258
312 STREPTOCOCCAL INFECTION 143 0.0257
313 ILLNESS 2630 0.0255
314 MIGRAINE 2436 0.0255
315 MOTOR DYSFUNCTION 260 0.0255
316 INJECTION SITE BRUISING 2034 0.0255
317 SYNOVIAL CYST 117 0.0253
318 MOVEMENT DISORDER 813 0.0253
319 PAIN IN EXTREMITY 7432 0.0252
320 URTICARIA 4160 0.0248
321 PRURITUS 9542 0.0248
322 LIMB DISCOMFORT 762 0.0246
323 SPINAL DISORDER 233 0.0246
324 DISCOURAGEMENT 57 0.0244
325 RHINORRHOEA 1553 0.0240
326 LIPOMA 62 0.0239
327 RESPIRATORY TRACT CONGESTION 379 0.0238
328 CELLULITIS 1200 0.0238
329 CORONAVIRUS INFECTION 157 0.0237
330 EYE INFECTION 267 0.0236
331 VITILIGO 55 0.0234
332 CYST 290 0.0233
333 IMMUNOSUPPRESSION 206 0.0233
334 DYSPEPSIA 2281 0.0232
335 AFFECT LABILITY 223 0.0231
336 LYME DISEASE 77 0.0231
337 ORAL HERPES 450 0.0230
338 COVID-19 4028 0.0229
339 SENSITIVITY TO WEATHER CHANGE 120 0.0228
340 VAGINAL INFECTION 107 0.0227
341 NODULE 296 0.0227
342 DYSSTASIA 662 0.0226
343 FUNGAL INFECTION 754 0.0226
344 JOINT LOCK 64 0.0225
345 RESPIRATORY DISORDER 673 0.0225
346 SINUS DISORDER 442 0.0223
347 DRUG INEFFECTIVE 29381 0.0223
348 GASTROINTESTINAL INFECTION 199 0.0222
349 SNEEZING 496 0.0221
350 DISABILITY 436 0.0220
351 SKIN ATROPHY 126 0.0219
352 MALAISE 9598 0.0219
353 RESPIRATORY TRACT INFECTION 569 0.0218
354 BODY TEMPERATURE DECREASED 215 0.0218
355 BRONCHITIS 1616 0.0218
356 ULCER 344 0.0216
357 ACCIDENT 258 0.0216
358 OSTEOPOROSIS 886 0.0215
359 COLITIS MICROSCOPIC 102 0.0215
360 OVERWEIGHT 115 0.0214
361 RASH 9297 0.0213
362 GASTROOESOPHAGEAL REFLUX DISEASE 1716 0.0213
363 INCORRECT DOSAGE ADMINISTERED 104 0.0212
364 HEPATIC ENZYME ABNORMAL 106 0.0212
365 EAR DISORDER 97 0.0212
366 MOUTH ULCERATION 446 0.0211
367 CREPITATIONS 63 0.0211
368 CYSTITIS 672 0.0211
369 TOOTH INFECTION 275 0.0208
370 VIRAL UPPER RESPIRATORY TRACT INFECTION 99 0.0208
371 BASAL CELL CARCINOMA 323 0.0207
372 HYPERTENSION 4381 0.0207
373 RASH PUSTULAR 150 0.0206
374 MEMORY IMPAIRMENT 2800 0.0204
375 CONFUSIONAL STATE 3287 0.0203
376 TONGUE DISORDER 147 0.0203
377 INCORRECT DOSE ADMINISTERED 4622 0.0202
378 ARTHROPOD BITE 150 0.0202
379 AMNESIA 1312 0.0201
380 RESPIRATORY SYMPTOM 57 0.0200
381 MUSCULAR WEAKNESS 2276 0.0200
382 ORAL INFECTION 78 0.0199
383 CHONDROPATHY 54 0.0199
384 WEIGHT FLUCTUATION 208 0.0199
385 NASAL CONGESTION 1168 0.0199
386 MENISCUS INJURY 122 0.0198
387 FREQUENT BOWEL MOVEMENTS 534 0.0197
388 POSTOPERATIVE WOUND INFECTION 133 0.0197
389 BONE LESION 71 0.0197
390 SKIN ABRASION 93 0.0197
391 PURULENT DISCHARGE 84 0.0196
392 THERAPEUTIC RESPONSE DELAYED 55 0.0196
393 PRODUCT USE ISSUE 3670 0.0195
394 HEPATIC FIBROSIS 67 0.0195
395 ARTHRITIS BACTERIAL 80 0.0195
396 TENDON PAIN 147 0.0194
397 NAIL DISCOLOURATION 76 0.0193
398 DEVICE ISSUE 1730 0.0193
399 SUSPECTED OFF LABEL USE 87 0.0192
400 SKIN EROSION 62 0.0192
401 GAIT DISTURBANCE 3681 0.0192
402 OROPHARYNGEAL DISCOMFORT 173 0.0191
403 DIVERTICULITIS 530 0.0191
404 TRIGGER FINGER 78 0.0191
405 PRODUCT AVAILABILITY ISSUE 432 0.0190
406 SCAR 324 0.0189
407 SPINAL STENOSIS 78 0.0189
408 JOINT INJURY 400 0.0187
409 BACK PAIN 4346 0.0187
410 PEPTIC ULCER 62 0.0187
411 WOUND SECRETION 73 0.0186
412 COLITIS ULCERATIVE 832 0.0186
413 ABDOMINAL PAIN UPPER 3819 0.0185
414 SKIN DISCOLOURATION 850 0.0185
415 DIARRHOEA HAEMORRHAGIC 172 0.0184
416 HYPERKERATOSIS 101 0.0183
417 HEPATIC STEATOSIS 340 0.0182
418 VARICOSE VEIN 94 0.0182
419 SPINAL OSTEOARTHRITIS 157 0.0179
420 VIRAL INFECTION 589 0.0177
421 ROSACEA 82 0.0176
422 FUNGAL SKIN INFECTION 71 0.0176
423 EATING DISORDER 369 0.0173
424 MASS 242 0.0173
425 ONYCHOCLASIS 119 0.0173
426 OTITIS MEDIA 57 0.0172
427 GASTROENTERITIS VIRAL 311 0.0172
428 THERAPEUTIC RESPONSE DECREASED 1044 0.0172
429 TENDON INJURY 64 0.0172
430 INTERVERTEBRAL DISC DEGENERATION 159 0.0172
431 SKIN ULCER 443 0.0171
432 GASTROINTESTINAL PAIN 188 0.0171
433 STAPHYLOCOCCAL INFECTION 559 0.0169
434 COLITIS 641 0.0169
435 WEIGHT INCREASED 3786 0.0169
436 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 286 0.0168
437 RASH MACULAR 588 0.0168
438 VULVOVAGINAL MYCOTIC INFECTION 66 0.0168
439 SKIN SWELLING 144 0.0166
440 ASTHMA 1875 0.0166
441 PRODUCT DOSE OMISSION ISSUE 4864 0.0165
442 SKIN WEEPING 59 0.0165
443 ERYTHEMA NODOSUM 58 0.0165
444 MUSCULOSKELETAL CHEST PAIN 255 0.0165
445 COORDINATION ABNORMAL 229 0.0164
446 NEAR DEATH EXPERIENCE 54 0.0163
447 PRODUCT USE IN UNAPPROVED INDICATION 4054 0.0163
448 LIMB INJURY 442 0.0163
449 FACIAL PARALYSIS 138 0.0162
450 PNEUMONIA 5240 0.0162
451 PYREXIA 5600 0.0162
452 PARANASAL SINUS DISCOMFORT 61 0.0161
453 THERAPY INTERRUPTED 1137 0.0159
454 CHAPPED LIPS 69 0.0159
455 PHARYNGEAL SWELLING 155 0.0158
456 PRODUCT STORAGE ERROR 1381 0.0158
457 ADRENAL INSUFFICIENCY 191 0.0157
458 PARAESTHESIA 2476 0.0157
459 WOUND COMPLICATION 54 0.0157
460 INJECTION SITE REACTION 1079 0.0157
461 THYROID MASS 60 0.0156
462 BLOOD CREATININE ABNORMAL 54 0.0156
463 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 748 0.0156
464 INJECTION SITE HAEMORRHAGE 1242 0.0155
465 DRUG EFFECT DELAYED 70 0.0154
466 MONOCYTE COUNT INCREASED 56 0.0154
467 ORAL PAIN 345 0.0154
468 SPUTUM DISCOLOURED 146 0.0154
469 ADVERSE DRUG REACTION 1381 0.0154
470 SARCOIDOSIS 73 0.0154
471 ANOSMIA 222 0.0153
472 DIVERTICULUM INTESTINAL 67 0.0153
473 MALIGNANT MELANOMA 205 0.0153
474 POST PROCEDURAL INFECTION 124 0.0152
475 LIGAMENT SPRAIN 150 0.0152
476 RED CELL DISTRIBUTION WIDTH INCREASED 63 0.0151
477 DRUG EFFECT LESS THAN EXPECTED 223 0.0150
478 NEPHROLITHIASIS 690 0.0150
479 BLOOD PRESSURE SYSTOLIC INCREASED 292 0.0150
480 COUGH 4184 0.0149
481 PYELONEPHRITIS 129 0.0149
482 NASAL DRYNESS 93 0.0148
483 DERMATITIS 310 0.0148
484 HYPOACUSIS 636 0.0148
485 MUSCLE SPASMS 2703 0.0147
486 FRUSTRATION TOLERANCE DECREASED 119 0.0147
487 EYE INFLAMMATION 140 0.0147
488 DEVICE DEPLOYMENT ISSUE 187 0.0146
489 GROIN PAIN 128 0.0146
490 PRODUCT DOSE OMISSION 950 0.0145
491 PRODUCT DISPENSING ISSUE 62 0.0145
492 BACTERIAL INFECTION 270 0.0145
493 GINGIVITIS 78 0.0144
494 HERPES VIRUS INFECTION 83 0.0144
495 GASTRIC INFECTION 55 0.0144
496 APHONIA 200 0.0143
497 ERYTHEMA 2945 0.0143
498 HERPES ZOSTER 815 0.0142
499 ABSCESS 226 0.0142
500 CHEST PAIN 2620 0.0141
501 SKIN REACTION 199 0.0141
502 PRODUCT DISPENSING ERROR 306 0.0140
503 HEMIPARESIS 238 0.0140
504 FEELING HOT 861 0.0140
505 TENDON DISORDER 91 0.0139
506 TONGUE DISCOLOURATION 61 0.0139
507 FATIGUE 10786 0.0138
508 PULMONARY MASS 206 0.0138
509 INFLUENZA LIKE ILLNESS 1138 0.0138
510 ORAL DISORDER 101 0.0138
511 DRUG ERUPTION 244 0.0138
512 INTERVERTEBRAL DISC PROTRUSION 300 0.0137
513 APPENDICITIS 128 0.0137
514 BURNING SENSATION 949 0.0135
515 CONJUNCTIVITIS 250 0.0135
516 RASH PRURITIC 729 0.0134
517 THERMAL BURN 95 0.0134
518 ANGINA PECTORIS 382 0.0133
519 DEVICE DELIVERY SYSTEM ISSUE 365 0.0133
520 MATERNAL EXPOSURE BEFORE PREGNANCY 91 0.0133
521 UNDERDOSE 970 0.0133
522 DECREASED APPETITE 3070 0.0132
523 INJECTION SITE DISCOMFORT 139 0.0132
524 LYMPHADENOPATHY 466 0.0132
525 PRODUCTIVE COUGH 622 0.0130
526 NASAL DISCOMFORT 103 0.0130
527 ADVERSE EVENT 1194 0.0129
528 DEPRESSION 2938 0.0129
529 URINARY TRACT INFECTION 2202 0.0129
530 FEELING OF DESPAIR 60 0.0129
531 GLUCOSE TOLERANCE IMPAIRED 76 0.0128
532 DRUG DOSE OMISSION BY DEVICE 1001 0.0128
533 EAR DISCOMFORT 131 0.0128
534 DIARRHOEA 8168 0.0126
535 HYPERTRANSAMINASAEMIA 88 0.0126
536 INJECTION SITE DISCHARGE 68 0.0126
537 GASTROINTESTINAL INFLAMMATION 99 0.0126
538 UPPER-AIRWAY COUGH SYNDROME 104 0.0126
539 SUNBURN 94 0.0126
540 DIABETES MELLITUS 958 0.0126
541 WHITE BLOOD CELL COUNT INCREASED 482 0.0126
542 INSOMNIA 3344 0.0125
543 RECTAL HAEMORRHAGE 537 0.0125
544 SKIN HYPERPIGMENTATION 107 0.0124
545 INFARCTION 85 0.0124
546 BOWEL MOVEMENT IRREGULARITY 95 0.0124
547 THERAPY CESSATION 635 0.0124
548 PULMONARY CONGESTION 163 0.0124
549 BLOOD PRESSURE DIASTOLIC INCREASED 57 0.0123
550 FOOD POISONING 66 0.0123
551 ROTATOR CUFF SYNDROME 156 0.0121
552 NERVE COMPRESSION 111 0.0120
553 SEASONAL ALLERGY 170 0.0120
554 GUILLAIN-BARRE SYNDROME 58 0.0120
555 DRY SKIN 1592 0.0119
556 HEADACHE 7440 0.0119
557 PRODUCT ADMINISTRATION ERROR 239 0.0118
558 MEDICATION ERROR 657 0.0118
559 ABDOMINAL DISTENSION 1229 0.0118
560 OSTEOMYELITIS 213 0.0118
561 ODYNOPHAGIA 70 0.0117
562 INJECTION SITE PAIN 3590 0.0117
563 ECZEMA 609 0.0116
564 HYPERCALCAEMIA 143 0.0116
565 MUSCLE STRAIN 100 0.0115
566 INJECTION SITE INJURY 64 0.0115
567 OEDEMA PERIPHERAL 1406 0.0115
568 HEAD DISCOMFORT 204 0.0115
569 COVID-19 PNEUMONIA 136 0.0115
570 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 538 0.0115
571 DEAFNESS 301 0.0115
572 BREAST MASS 77 0.0115
573 GASTROENTERITIS 167 0.0114
574 INCORRECT ROUTE OF DRUG ADMINISTRATION 407 0.0114
575 RASH ERYTHEMATOUS 543 0.0113
576 BLOOD TEST ABNORMAL 159 0.0113
577 SENSITIVE SKIN 83 0.0112
578 ANKLE FRACTURE 173 0.0112
579 ANAL ABSCESS 60 0.0111
580 HAND FRACTURE 78 0.0110
581 GOUT 197 0.0110
582 TOOTHACHE 197 0.0109
583 BODY TEMPERATURE INCREASED 222 0.0109
584 DYSLIPIDAEMIA 55 0.0108
585 ABDOMINAL PAIN 2512 0.0108
586 ASTHENIA 4060 0.0108
587 APHASIA 325 0.0108
588 BREATH SOUNDS ABNORMAL 53 0.0107
589 ENTERITIS 68 0.0106
590 SQUAMOUS CELL CARCINOMA 100 0.0106
591 HERPES SIMPLEX 69 0.0106
592 SQUAMOUS CELL CARCINOMA OF SKIN 64 0.0106
593 AGEUSIA 264 0.0106
594 CARPAL TUNNEL SYNDROME 147 0.0105
595 DERMATITIS CONTACT 119 0.0104
596 WEIGHT DECREASED 2897 0.0104
597 INGUINAL HERNIA 63 0.0103
598 CONCUSSION 80 0.0103
599 VOMITING 4828 0.0103
600 DERMATITIS ALLERGIC 129 0.0102
601 METASTASES TO LYMPH NODES 69 0.0102
602 LYMPHOMA 156 0.0101
603 FOOT FRACTURE 191 0.0101
604 PELVIC PAIN 183 0.0101
605 VITAMIN D DEFICIENCY 98 0.0100
606 URINE ODOUR ABNORMAL 59 0.0100
607 VISUAL IMPAIRMENT 1237 0.0100
608 RENAL CYST 79 0.0099
609 VITAMIN D DECREASED 85 0.0099
610 EYE DISCHARGE 103 0.0099
611 GASTRITIS 260 0.0099
612 INSURANCE ISSUE 151 0.0099
613 FEELING ABNORMAL 2342 0.0098
614 CATARACT 582 0.0098
615 PLEURISY 58 0.0098
616 INJECTION SITE VESICLES 59 0.0097
617 BLOOD URIC ACID INCREASED 56 0.0097
618 LARGE INTESTINE POLYP 67 0.0097
619 HEPATOMEGALY 95 0.0097
620 BONE DISORDER 176 0.0096
621 RENAL PAIN 102 0.0096
622 PRURITUS GENERALISED 208 0.0096
623 SKIN IRRITATION 440 0.0096
624 FLUID RETENTION 488 0.0096
625 BONE PAIN 561 0.0096
626 HEPATITIS B 57 0.0094
627 PANCREATITIS 499 0.0094
628 SINUS HEADACHE 56 0.0094
629 DYSURIA 346 0.0094
630 NERVOUSNESS 491 0.0094
631 ANXIETY 2672 0.0094
632 INJECTION SITE DISCOLOURATION 117 0.0094
633 VASCULITIS 109 0.0093
634 ENERGY INCREASED 55 0.0093
635 NEOPLASM 107 0.0093
636 LABORATORY TEST ABNORMAL 272 0.0092
637 ORAL DISCOMFORT 128 0.0092
638 HERNIA 178 0.0092
639 POLYP 60 0.0092
640 QUALITY OF LIFE DECREASED 122 0.0091
641 RIB FRACTURE 187 0.0091
642 INJECTION SITE EXTRAVASATION 112 0.0091
643 INJECTION SITE MASS 335 0.0091
644 DRY THROAT 92 0.0090
645 PRODUCT PACKAGING ISSUE 86 0.0090
646 DYSPHONIA 529 0.0090
647 AFFECTIVE DISORDER 71 0.0090
648 DIZZINESS 4503 0.0090
649 DEFORMITY 84 0.0090
650 UPPER LIMB FRACTURE 178 0.0089
651 THERAPY PARTIAL RESPONDER 138 0.0088
652 SENSATION OF FOREIGN BODY 74 0.0088
653 HYPERAESTHESIA 72 0.0088
654 DEPRESSED MOOD 461 0.0087
655 DYSPNOEA 4929 0.0087
656 HAEMATOCHEZIA 480 0.0087
657 DRUG EFFECT DECREASED 466 0.0086
658 SKIN LACERATION 94 0.0086
659 SKIN CANCER 185 0.0086
660 NEOPLASM MALIGNANT 572 0.0086
661 GENERAL PHYSICAL CONDITION ABNORMAL 58 0.0085
662 FEEDING DISORDER 173 0.0085
663 FALL 2838 0.0085
664 THYROID DISORDER 131 0.0085
665 TENDON RUPTURE 104 0.0084
666 DEVICE FAILURE 128 0.0084
667 GLOMERULAR FILTRATION RATE DECREASED 103 0.0084
668 DISEASE RECURRENCE 396 0.0083
669 NAUSEA 6523 0.0082
670 THROAT IRRITATION 367 0.0082
671 WRIST FRACTURE 98 0.0082
672 NEURALGIA 197 0.0081
673 OFF LABEL USE 7053 0.0080
674 MUSCULOSKELETAL DISORDER 153 0.0080
675 CHEST DISCOMFORT 820 0.0080
676 CEREBRAL DISORDER 59 0.0080
677 DYSARTHRIA 300 0.0080
678 PHOTOSENSITIVITY REACTION 131 0.0079
679 DIVERTICULUM 56 0.0079
680 SWELLING FACE 513 0.0079
681 PEMPHIGOID 59 0.0078
682 BLOOD ALBUMIN DECREASED 62 0.0078
683 LOW DENSITY LIPOPROTEIN INCREASED 60 0.0077
684 HAEMORRHOIDS 150 0.0077
685 PRODUCT QUALITY ISSUE 1042 0.0077
686 CHILLS 899 0.0077
687 GASTRIC ULCER 145 0.0076
688 DYSPHAGIA 724 0.0076
689 GASTRIC DISORDER 261 0.0076
690 BLOOD URINE PRESENT 142 0.0075
691 ACNE 567 0.0075
692 BLADDER DISORDER 74 0.0074
693 BLOOD PRESSURE DIASTOLIC DECREASED 55 0.0074
694 SWOLLEN TONGUE 232 0.0074
695 DRUG PRESCRIBING ERROR 142 0.0074
696 INTENTIONAL DOSE OMISSION 210 0.0074
697 SLUGGISHNESS 75 0.0073
698 TOOTH FRACTURE 81 0.0073
699 BLOOD PRESSURE INCREASED 1118 0.0073
700 INCORRECT PRODUCT STORAGE 96 0.0073
701 GINGIVAL PAIN 58 0.0073
702 PLATELET COUNT INCREASED 95 0.0073
703 BRAIN INJURY 73 0.0073
704 BLOOD TRIGLYCERIDES INCREASED 128 0.0072
705 MENTAL DISORDER 313 0.0072
706 TEMPERATURE INTOLERANCE 74 0.0072
707 ALANINE AMINOTRANSFERASE INCREASED 439 0.0071
708 BREAST PAIN 76 0.0071
709 SLEEP APNOEA SYNDROME 136 0.0071
710 LIP SWELLING 237 0.0071
711 SKIN BURNING SENSATION 507 0.0071
712 HIATUS HERNIA 91 0.0070
713 FISTULA 79 0.0070
714 MUSCLE ATROPHY 89 0.0070
715 EYE SWELLING 261 0.0070
716 ARTERIOSCLEROSIS 66 0.0070
717 POOR QUALITY SLEEP 150 0.0070
718 AORTIC ANEURYSM 53 0.0070
719 FACIAL PAIN 62 0.0069
720 FLANK PAIN 65 0.0069
721 EJECTION FRACTION DECREASED 107 0.0069
722 OCULAR HYPERAEMIA 324 0.0068
723 ESCHERICHIA INFECTION 56 0.0068
724 TRANSAMINASES INCREASED 151 0.0068
725 DECREASED ACTIVITY 73 0.0068
726 PHOTOPHOBIA 127 0.0067
727 BLOOD IRON DECREASED 80 0.0067
728 THYROID CANCER 81 0.0067
729 EYE DISORDER 221 0.0067
730 COLON CANCER 100 0.0067
731 INCORRECT PRODUCT ADMINISTRATION DURATION 143 0.0066
732 INJECTION SITE SWELLING 500 0.0065
733 CEREBROVASCULAR ACCIDENT 1084 0.0064
734 EMPHYSEMA 64 0.0063
735 DRY EYE 316 0.0063
736 FEAR 170 0.0063
737 SPEECH DISORDER 329 0.0063
738 FEELING COLD 174 0.0062
739 MUSCLE TIGHTNESS 101 0.0062
740 MYALGIA 1060 0.0062
741 ANAPHYLACTIC REACTION 344 0.0062
742 NERVE INJURY 69 0.0062
743 CHOLELITHIASIS 203 0.0062
744 LUNG INFECTION 96 0.0062
745 LETHARGY 353 0.0061
746 BLOOD PRESSURE ABNORMAL 121 0.0061
747 THROAT TIGHTNESS 162 0.0060
748 VERTIGO 365 0.0060
749 MIDDLE INSOMNIA 111 0.0059
750 RASH GENERALISED 153 0.0059
751 CRYING 214 0.0059
752 OCULAR DISCOMFORT 66 0.0059
753 OSTEOPENIA 89 0.0059
754 RENAL DISORDER 273 0.0059
755 REBOUND EFFECT 66 0.0058
756 CARDIAC DISORDER 545 0.0058
757 POLLAKIURIA 242 0.0058
758 THERAPY CHANGE 57 0.0058
759 ABDOMINAL PAIN LOWER 146 0.0058
760 LACRIMATION INCREASED 173 0.0057
761 GALLBLADDER DISORDER 102 0.0057
762 SEPSIS 637 0.0057
763 INJECTION SITE URTICARIA 140 0.0057
764 LEUKOPENIA 284 0.0057
765 POST PROCEDURAL COMPLICATION 109 0.0057
766 SYRINGE ISSUE 98 0.0056
767 PARALYSIS 80 0.0056
768 HYPERHIDROSIS 718 0.0056
769 TACHYCARDIA 495 0.0056
770 ASPIRATION 61 0.0056
771 ACUTE MYOCARDIAL INFARCTION 164 0.0056
772 PARAESTHESIA ORAL 80 0.0055
773 HYPERLIPIDAEMIA 66 0.0055
774 MUSCLE RIGIDITY 66 0.0055
775 HIP FRACTURE 177 0.0055
776 SPINAL FRACTURE 110 0.0055
777 ASPARTATE AMINOTRANSFERASE INCREASED 288 0.0054
778 PRODUCT PRESCRIBING ISSUE 118 0.0054
779 BREAST CANCER 504 0.0054
780 DEVICE MECHANICAL ISSUE 74 0.0054
781 EYE PRURITUS 180 0.0054
782 CLOSTRIDIUM DIFFICILE INFECTION 116 0.0053
783 HYPERSOMNIA 152 0.0053
784 SEXUAL DYSFUNCTION 62 0.0053
785 CHOKING 103 0.0053
786 SPINAL OPERATION 65 0.0053
787 NEUTROPHIL COUNT INCREASED 54 0.0053
788 BLOOD CREATININE INCREASED 343 0.0052
789 EXPOSURE VIA SKIN CONTACT 135 0.0052
790 PHARYNGEAL OEDEMA 80 0.0052
791 PALPITATIONS 607 0.0052
792 NERVOUS SYSTEM DISORDER 161 0.0052
793 DEMENTIA 144 0.0051
794 OESOPHAGITIS 56 0.0051
795 BRAIN FOG 80 0.0051
796 HEAD INJURY 158 0.0050
797 MICTURITION URGENCY 57 0.0050
798 HEPATITIS C 60 0.0050
799 INJURY ASSOCIATED WITH DEVICE 101 0.0050
800 EYE PAIN 279 0.0049
801 INJECTION SITE PRURITUS 329 0.0049
802 SPLENOMEGALY 57 0.0049
803 PROSTATIC SPECIFIC ANTIGEN INCREASED 67 0.0049
804 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 253 0.0048
805 ANGIOEDEMA 214 0.0048
806 HAEMORRHAGE 504 0.0048
807 HYPOTHYROIDISM 153 0.0048
808 CHROMATURIA 108 0.0048
809 HYPOAESTHESIA ORAL 72 0.0048
810 BLINDNESS UNILATERAL 67 0.0047
811 NO ADVERSE EVENT 859 0.0047
812 FOETAL EXPOSURE DURING PREGNANCY 385 0.0047
813 INJECTION SITE RASH 145 0.0047
814 HYPOKALAEMIA 217 0.0047
815 THROMBOSIS 377 0.0047
816 GENERALISED OEDEMA 58 0.0047
817 HEART RATE INCREASED 464 0.0047
818 PANIC ATTACK 170 0.0047
819 PAIN IN JAW 131 0.0046
820 ABORTION SPONTANEOUS 185 0.0046
821 THERAPEUTIC RESPONSE UNEXPECTED 207 0.0046
822 HYPERTHYROIDISM 66 0.0046
823 COLD SWEAT 80 0.0045
824 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 249 0.0045
825 GAMMA-GLUTAMYLTRANSFERASE INCREASED 100 0.0045
826 FRACTURE 85 0.0045
827 LUNG NEOPLASM MALIGNANT 183 0.0044
828 CHOLECYSTITIS 53 0.0044
829 PERIPHERAL COLDNESS 61 0.0044
830 SURGERY 259 0.0044
831 RASH PAPULAR 99 0.0044
832 LOSS OF CONSCIOUSNESS 564 0.0044
833 CORONARY ARTERY DISEASE 133 0.0044
834 MYOCARDIAL INFARCTION 766 0.0044
835 GLAUCOMA 83 0.0043
836 INJECTION SITE WARMTH 88 0.0043
837 SUICIDAL IDEATION 391 0.0043
838 HOT FLUSH 320 0.0042
839 FAECES DISCOLOURED 92 0.0042
840 TRANSIENT ISCHAEMIC ATTACK 142 0.0042
841 HAEMATURIA 144 0.0042
842 TOOTH DISORDER 93 0.0042
843 BLINDNESS 170 0.0042
844 CORONARY ARTERY OCCLUSION 57 0.0042
845 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 838 0.0041
846 FLATULENCE 234 0.0041
847 LIVER FUNCTION TEST ABNORMAL 120 0.0041
848 HYPOCALCAEMIA 78 0.0041
849 RENAL IMPAIRMENT 346 0.0041
850 MULTIPLE SCLEROSIS 193 0.0040
851 FACE OEDEMA 68 0.0040
852 DEVICE RELATED INFECTION 62 0.0040
853 SEPTIC SHOCK 174 0.0040
854 BLOOD PRESSURE DECREASED 264 0.0040
855 HAEMATOCRIT DECREASED 78 0.0039
856 MOOD ALTERED 107 0.0039
857 URINARY INCONTINENCE 115 0.0039
858 INJECTION SITE ERYTHEMA 481 0.0039
859 DEVICE USE ISSUE 67 0.0038
860 EMOTIONAL DISORDER 117 0.0038
861 PNEUMOTHORAX 60 0.0038
862 DRUG RESISTANCE 97 0.0038
863 HEPATOTOXICITY 84 0.0038
864 MOOD SWINGS 120 0.0038
865 SENSORY DISTURBANCE 60 0.0037
866 HAEMOPTYSIS 104 0.0037
867 SYNCOPE 372 0.0037
868 PRODUCT DOSE OMISSION IN ERROR 105 0.0037
869 ATRIAL FIBRILLATION 361 0.0037
870 HOSPITALISATION 563 0.0037
871 RESTLESS LEGS SYNDROME 66 0.0036
872 DYSPNOEA EXERTIONAL 135 0.0036
873 PLEURAL EFFUSION 216 0.0035
874 DRUG DISPENSING ERROR 54 0.0035
875 TOOTH LOSS 72 0.0035
876 FEMUR FRACTURE 107 0.0035
877 GLYCOSYLATED HAEMOGLOBIN INCREASED 87 0.0034
878 INTERSTITIAL LUNG DISEASE 164 0.0034
879 ISCHAEMIC STROKE 60 0.0034
880 THIRST 60 0.0034
881 DRUG ADMINISTRATION ERROR 103 0.0034
882 PROCEDURAL PAIN 93 0.0033
883 PRESYNCOPE 81 0.0033
884 PALLOR 90 0.0033
885 HEART RATE DECREASED 116 0.0033
886 PROSTATE CANCER 265 0.0033
887 ARRHYTHMIA 156 0.0033
888 BLOOD PRESSURE FLUCTUATION 79 0.0033
889 RED BLOOD CELL COUNT DECREASED 93 0.0032
890 DIABETES MELLITUS INADEQUATE CONTROL 57 0.0032
891 NEUROPATHY PERIPHERAL 305 0.0032
892 VISION BLURRED 437 0.0032
893 ANGER 107 0.0032
894 DEVICE DIFFICULT TO USE 209 0.0032
895 TINNITUS 145 0.0032
896 DEEP VEIN THROMBOSIS 203 0.0031
897 DEVICE USE ERROR 108 0.0031
898 SOMNOLENCE 619 0.0031
899 LYMPHOCYTE COUNT DECREASED 54 0.0031
900 THROMBOCYTOPENIA 339 0.0030
901 ANAPHYLACTIC SHOCK 78 0.0030
902 BLOOD GLUCOSE ABNORMAL 55 0.0030
903 HAEMATOMA 77 0.0030
904 TREATMENT NONCOMPLIANCE 160 0.0029
905 MUCOSAL INFLAMMATION 76 0.0029
906 BLOOD ALKALINE PHOSPHATASE INCREASED 72 0.0029
907 DEATH 2493 0.0029
908 CARDIAC FAILURE CONGESTIVE 232 0.0029
909 CARDIOVASCULAR DISORDER 73 0.0029
910 PNEUMONITIS 78 0.0029
911 ERUCTATION 55 0.0028
912 CARDIAC FAILURE 225 0.0028
913 HEPATIC CANCER 66 0.0027
914 EPISTAXIS 205 0.0027
915 HEPATIC FAILURE 82 0.0027
916 DERMATITIS ATOPIC 142 0.0027
917 ERECTILE DYSFUNCTION 69 0.0027
918 BALANCE DISORDER 232 0.0027
919 CONSTIPATION 585 0.0027
920 DEHYDRATION 357 0.0027
921 DEVICE BREAKAGE 108 0.0027
922 HEART RATE IRREGULAR 60 0.0027
923 BLOOD GLUCOSE INCREASED 498 0.0026
924 WHITE BLOOD CELL COUNT DECREASED 285 0.0026
925 EMOTIONAL DISTRESS 318 0.0026
926 EYE IRRITATION 151 0.0026
927 INTESTINAL OBSTRUCTION 98 0.0026
928 SEIZURE 300 0.0026
929 ASCITES 76 0.0026
930 IRRITABILITY 155 0.0026
931 ANAEMIA 491 0.0026
932 PULMONARY EMBOLISM 244 0.0026
933 OSTEONECROSIS 84 0.0026
934 PERICARDIAL EFFUSION 59 0.0025
935 HAEMOGLOBIN DECREASED 260 0.0025
936 TREMOR 417 0.0025
937 URINARY RETENTION 83 0.0025
938 PANCREATITIS ACUTE 55 0.0024
939 DYSGEUSIA 181 0.0024
940 BLOOD POTASSIUM DECREASED 73 0.0024
941 HYPOTENSION 487 0.0024
942 DIPLOPIA 63 0.0024
943 COGNITIVE DISORDER 113 0.0024
944 MULTIPLE ORGAN DYSFUNCTION SYNDROME 67 0.0024
945 MENTAL IMPAIRMENT 57 0.0023
946 PULMONARY OEDEMA 105 0.0023
947 MUSCLE TWITCHING 54 0.0023
948 CEREBRAL INFARCTION 57 0.0023
949 RENAL FAILURE 309 0.0023
950 RESTLESSNESS 85 0.0023
951 UNEVALUABLE EVENT 175 0.0023
952 BLOOD BILIRUBIN INCREASED 60 0.0022
953 OXYGEN SATURATION DECREASED 122 0.0022
954 FLUSHING 215 0.0021
955 PANCREATIC CARCINOMA 61 0.0021
956 BLOOD GLUCOSE DECREASED 101 0.0021
957 OVERDOSE 450 0.0021
958 DISORIENTATION 82 0.0021
959 HEPATIC FUNCTION ABNORMAL 75 0.0020
960 JAUNDICE 54 0.0020
961 ACCIDENTAL OVERDOSE 71 0.0019
962 EXPIRED PRODUCT ADMINISTERED 64 0.0019
963 NIGHTMARE 66 0.0019
964 CEREBRAL HAEMORRHAGE 68 0.0019
965 HYPOGLYCAEMIA 91 0.0019
966 INTENTIONAL PRODUCT MISUSE 156 0.0018
967 DISEASE PROGRESSION 208 0.0018
968 GASTROINTESTINAL HAEMORRHAGE 144 0.0017
969 DISTURBANCE IN ATTENTION 92 0.0017
970 PLATELET COUNT DECREASED 174 0.0016
971 HYPERGLYCAEMIA 56 0.0015
972 RESPIRATORY FAILURE 111 0.0015
973 BLADDER CANCER 88 0.0015
974 RENAL CANCER 71 0.0015
975 EXTRA DOSE ADMINISTERED 60 0.0015
976 VAGINAL HAEMORRHAGE 64 0.0015
977 AGITATION 107 0.0015
978 COMA 67 0.0014
979 CHRONIC KIDNEY DISEASE 102 0.0013
980 ACUTE KIDNEY INJURY 194 0.0013
981 DRUG INTERACTION 188 0.0012
982 CARDIAC ARREST 96 0.0012
983 PANCYTOPENIA 61 0.0011
984 SUICIDE ATTEMPT 63 0.0010
985 NEUTROPENIA 135 0.0010
986 DRUG DOSE OMISSION 135 0.0008
987 DRUG DEPENDENCE 63 0.0004
988 TOXICITY TO VARIOUS AGENTS 59 0.0003